C
ardiac resynchronisation therapy (CRT) is a new treatment strategy directed at improving left ventricular function in patients with congestive heart failure (CHF), by means of left ventricular pacing. CRT aims to correct the left ventricular conduction delay mostly observed in these patients, which can contribute to the interventricular and intraventricular mechanical asynchrony, and may therefore represent a primary curative approach. 1 2 Important multicentred studies have already established the effectiveness of CRT as treatment for CHF, by enhancing left ventricular function parameters and by improving quality of life and exercise tolerance. 3 4 However, there is concern over the relatively small number of patients so far enrolled in controlled trials, and the presence of a significant rate of ''non-responders''. Reasons for failure can be related to the inability of identifying and effectively stimulating those regions of myocardium which are mostly compromised by electromechanical desynchronisation. 5 6 In fact, the lead applied for CRT is empirically placed in different positions over a relatively wide area of the lateral and posterolateral epicardial wall of the left ventricle, guided by the variable anatomy of the coronary veins. 7 8 
IDENTIFYING THE OPTIMAL STIMULATION SITE
The use of the surface ECG is of limited value to guide the placement of the coronary sinus lead because it only measures the time of activation, 9 and it has been shown that similar left bundle branch block (LBBB) patterns are related to different conditions of activation of the left ventricle. 10 11 Haemodynamic parameters proved to be useful to define optimal pacing intervals 12 and to evaluate the acute response from different sites of pacing, 5 while new echocardiographic techniques showed additional importance in order to characterise candidates for CRT [13] [14] [15] [16] ; however, no method has so far been established to identify the optimal stimulation site in relation to the intraventricular defect of conduction and to long term efficacy.
Activation mapping has been only occasionally used to characterise the electrical pattern underlying the intraventricular conduction disturbance in each patient, and to identify those areas of delayed activation that benefit from local pacing. 17 In this setting, a dynamic mapping displaying the sequence of depolarisation could theoretically be of great value in identifying lines of block, in measuring activation intervals in different areas, and in estimating the effect of pacing from different sites.
The paper by Lambiase and colleagues 18 recently published in Heart shows that the use of ''non-contact'' mapping 19 adds significant elements to optimise CRT: the system allows the three dimensional reconstruction of the whole depolarisation process that takes part in the failing ventricle, and characterises areas of scar tissue and delayed activation, thereby defining the substrate of LBBB. This might represent the first step toward supporting a rational choice of a pacing site to restore an effective pattern of activation. The authors showed that areas of abnormal electrical activation are characterised by low amplitude electrograms and by prolonged propagation of depolarisation; furthermore, they proved that a significant haemodynamic improvement can be achieved by CRT only when left ventricular stimulation is applied outside of these ''slow conduction'' areas. When pacing is provided from within these areas, the recruitment of an adequate amount of tissue is compromised by the prolonged conduction throughout the paced area, making CRT less effective. In order to limit the harmful effect of delayed conduction from areas of slow conduction, Lambiase and colleagues 18 showed that in these patients the left chamber must be pre-excited by stimulating the left ventricle 32 ms before the right ventricle, causing the best coupling for the two ventricles; results of ''non-contact'' mapping will be compared in the future with those achieved by other techniques suggesting individually tailored preactivation of myocardium.
line of ''fixed'' conduction block: this may justify why areas of ''slow conduction'' are peculiar to patients with ischaemic cardiomyopathy who have suffered from previous myocardial damage, in whom effective pacing is limited by multiple anatomical barriers. In this setting, ''non-contact'' mapping should more accurately characterise the nature and the extension of conduction block, and act as a guide to the most effective place of pacing, both from within the coronary veins or from a ''true'' epicardial site. Because of the limited number of cases, however, Lambiase and colleagues 18 were not able to prove a direct correlation between areas of previous infarct and the site of ''block'' in their patient population: alternatively, one may suppose that a more diffuse endocardial damage of the specialised conduction system may be represented in patients with ischaemic cardiomyopathy. 10 Patients with idiopathic dilated cardiomyopathy, on the other hand, would present with a more functional disorder, that can be more easily corrected by means of local pacing. Further work is needed to clarify this issue.
Based on the experience of Lambiase and colleagues, 18 it is reasonable to expect that ''non-contact'' mapping in patients with LBBB who are candidates for CRT might be used to screen patients who benefit from this treatment. A precise, more ''qualitative'' characterisation of the pattern of activation, also considering the analysis of the electromechanical efficiency for different segments of the left chamber, will further shed light on the most suitable site for stimulation and clarify the importance of different future strategies for pacing, including multisite stimulation. 20 The major contribution offered by Lambiase and colleagues 18 is that a ''pure'' electrophysiological approach can guide CRT, given the extraordinary opportunity to look directly into the electrical pattern of left ventricular activation; left ventricular activation intervals can be reliably used to define the effectiveness of resynchronisation, and to guide lead implant for CRT, with a ''slow'' conduction being the key for future solutions.
